Relapsed classic Hodgkin lymphoma; should all patients receive an autologous stem cell transplant? – the PRO

Puntos clave

• To determine the necessity of autologous stem cell transplant in all patients with relapsed classic Hodgkin lymphoma.
• Assessment of treatment protocols for relapsed Hodgkin lymphoma
• Evaluation of patient outcomes with and without stem cell transplant
• Comparison of progression-free survival rates
• Findings suggest improved outcomes for patients receiving autologous stem cell transplant
• Not all patients may benefit, indicating a need for tailored treatment approaches
• Data shows varying success rates based on individual patient factors